Literature DB >> 11054529

Cloning and characterization of the human ameloblastin gene.

S Toyosawa1, T Fujiwara, T Ooshima, S Shintani, A Sato, Y Ogawa, S Sobue, N Ijuhin.   

Abstract

We isolated the full-length human ameloblastin (AMBN) cDNA clone using reverse transcription-polymerase chain reaction (RT-PCR) methods. Sequence analysis of the AMBN cDNA revealed an open reading frame of 1341bp encoding a 447-amino-acid protein. Comparison with pig, cattle, rat, and mouse AMBN sequences showed a high amino acid sequence similarity and led to the identification of a novel 78bp (26 amino acids) insert resulting from internal sequence duplication. By DNA analysis of a human genomic clones, the AMBN gene was shown to consist of 13 exons and a novel 78bp segment, which proved to comprise two small exons. Human ameloblastomas express AMBN transcripts that contain some mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054529     DOI: 10.1016/s0378-1119(00)00379-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Mineralized tissue and vertebrate evolution: the secretory calcium-binding phosphoprotein gene cluster.

Authors:  Kazuhiko Kawasaki; Kenneth M Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

2.  Msx and dlx homeogene expression in epithelial odontogenic tumors.

Authors:  Blandine Ruhin-Poncet; Sonia Ghoul-Mazgar; Dominique Hotton; Frédérique Capron; Mohamed Habib Jaafoura; Gérard Goubin; Ariane Berdal
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

3.  Critical role of heparin binding domains of ameloblastin for dental epithelium cell adhesion and ameloblastoma proliferation.

Authors:  Akira Sonoda; Tsutomu Iwamoto; Takashi Nakamura; Emiko Fukumoto; Keigo Yoshizaki; Aya Yamada; Makiko Arakaki; Hidemitsu Harada; Kazuaki Nonaka; Seiji Nakamura; Yoshihiko Yamada; Satoshi Fukumoto
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

4.  FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta.

Authors:  Jung-Wook Kim; Sook-Kyung Lee; Zang Hee Lee; Joo-Cheol Park; Kyung-Eun Lee; Myoung-Hwa Lee; Jong-Tae Park; Byoung-Moo Seo; Jan C-C Hu; James P Simmer
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

5.  Enzyme replacement prevents enamel defects in hypophosphatasia mice.

Authors:  Manisha C Yadav; Rodrigo Cardoso de Oliveira; Brian L Foster; Hanson Fong; Esther Cory; Sonoko Narisawa; Robert L Sah; Martha Somerman; Michael P Whyte; José Luis Millán
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

6.  Amelogenesis imperfecta: Report of a case and review of literature.

Authors:  Mayur Chaudhary; Shweta Dixit; Asha Singh; Sanket Kunte
Journal:  J Oral Maxillofac Pathol       Date:  2009-07

7.  Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts.

Authors:  Satoshi Fukumoto; Takayoshi Kiba; Bradford Hall; Noriyuki Iehara; Takashi Nakamura; Glenn Longenecker; Paul H Krebsbach; Antonio Nanci; Ashok B Kulkarni; Yoshihiko Yamada
Journal:  J Cell Biol       Date:  2004-12-06       Impact factor: 10.539

8.  Comparative expression of the four enamel matrix protein genes, amelogenin, ameloblastin, enamelin and amelotin during amelogenesis in the lizard Anolis carolinensis.

Authors:  Barbara Gasse; Jean-Yves Sire
Journal:  Evodevo       Date:  2015-09-29       Impact factor: 2.250

9.  Ameloblastin Peptides Modulates the Osteogenic Capacity of Human Mesenchymal Stem Cells.

Authors:  Øystein Stakkestad; Ståle P Lyngstadaas; Jiri Vondrasek; Jan O Gordeladze; Janne Elin Reseland
Journal:  Front Physiol       Date:  2017-02-07       Impact factor: 4.566

10.  Evolutionary analysis of selective constraints identifies ameloblastin (AMBN) as a potential candidate for amelogenesis imperfecta.

Authors:  Frédéric Delsuc; Barbara Gasse; Jean-Yves Sire
Journal:  BMC Evol Biol       Date:  2015-07-30       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.